Proton pump inhibitor therapy in atazanavir-treated patients: contraindicated?
Kari J
KJ
Furtek
Nancy F
NF
Crum
Patrick E
PE
Olson
Mark R
MR
Wallace
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000863:Antacids / Q000008:administration & dosage* / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D000069446:Atazanavir Sulfate; D001562:Benzimidazoles / Q000008:administration & dosage* / Q000627:therapeutic use; D000075202:Contraindications; D004347:Drug Interactions; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D009842:Oligopeptides / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D009853:Omeprazole / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D054328:Proton Pump Inhibitors; D011725:Pyridines / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D064750:Rabeprazole; D019438:Ritonavir / Q000008:administration & dosage / Q000627:therapeutic use
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000863:Antacids; D001562:Benzimidazoles; D017320:HIV Protease Inhibitors; D009842:Oligopeptides; D054328:Proton Pump Inhibitors; D011725:Pyridines; D064750:Rabeprazole; D000069446:Atazanavir Sulfate; D009853:Omeprazole; D019438:Ritonavir